Skip to Content


The cost of winning

Written by: Dan Empfield
Date: Mon Jun 15 2009

Just under a year ago the CSC professional cycling team—riding high with a Tour victory and years of stellar performances—entered into a de facto auction for its bike sponsor. In its hunt for money the team changed title from CSC to Saxo Bank - IT Factory. The IT Factory co-sponsorship (in fact the entire IT Factory company) would melt away as that firm’s managing director, Stein Bagger, was arrested and accused of engineering a Ponzi scheme.

The IT Factory sponsorship (entered into at the tail end of Bagger's fraudulent run); and the unprecedented sums required to be the team's new bike sponsor (reported to me by those directly involved in the negotiations); suggested to me that the posture of Bjarne Riis Cycling, owner of the Danish team, tilted toward money at the expense of due diligence and endemic technology partnerships. What has been the result of Riis Cycling's decisions, both on Cervelo, and the other involved parties?

I often accuse Gerard Vroomen, Cervelo’s president and co-founder, of spectacular good luck. Cervelo assembled a TT bike for Tyler Hamilton, riding for then-Look-sponsored CSC, and he ignored it. Laurent Jalabert picked up the discard and said, “Hmm, interesting, and my size! I’ll ride it.” Jalabert commenced to prologue the P3 to a virtual dead heat lead in the Tour de France prologue. Has to be luck. Right? And it’s only been gravy and "good luck" since.
Every time Vroomen, or his company, or his sponsored team, exits a relationship, that bad omen turns out to be a blessing in disguise. Hamilton quits the team and, as soon as he puts enough distance between himself and CSC to keep Cervelo safe from the shrapnel, he gets busted for drugs.

Enter Ivan Basso: Stellar TT results in a perfect position on a perfectly fitted P3 and then, busted. Basso was still with the team, still a Cervelo rider, at the commencement of his drug problems, but somehow this seemed not to spill over and onto the Cervelo headbadge.

And the victories kept coming. Zabriskie was a Cervelo sensation in time trials. He leaves for Slipsteam, no matter, then it’s Cancellara in the time trials. And Sastre wins the Tour aboard a Cervelo in 2008.

I don’t blame the rest of the bike world for having Cervelo envy. Specialized has endeavored hard to bag that maillot jaune in Paris. Reminiscent of Shimano trying to pull the yellow off Campagnolo's back all through the 80s and early 90s, here’s Specialized, doing everything “right.” Where’s the cosmic justice?
Several bike companies were involved in the Team Saxo Bank sweepstakes, and I don’t want to embarrass anyone, I’ll just say that the sums I heard from several teams involved in the bidding were astounding. Certainly much more than a company the size of Cervelo can afford. In Specialized, Riis found a match: Riis wanted money, Specialized wanted palmares (so much so that Specialized sponsors 2 of the 16 Pro Tour Teams (Saxo Bank and Quickstep) as well as one Continental Pro team (ISD).

Indeed, were Cervelo to have bought itself back into its Saxo Bank bike sponsorship, it could’ve formed its own, smaller, Continental Pro team for that money. Obviously, that idea was not lost on Cervelo and its management.

The non-endemic sponsor money has dried up in the wake of cycling’s drug scandals and a ruinous economy. The teams have taken to squeezing the product sponsors. Read our interview with Oval Concepts’ Morgan Nicol for an insider’s take on this (there's a link at this OpEd's terminus). As existing contracts expire, the money it takes today to bike-sponsor a top cycling team has tripled, quadrupled, or quintupled over just the last three or four years.

I’m writing now in reference to two notables: the Cervelo Test Team is not one of the 16 Pro Tour Teams. It is a Continental Pro Team, one rung down in the food chain. Nevertheless, it is the top professional cycling team in the world as of this writing—besting year-to-date all the Pro Tour Teams—based on its performance so far in 2009. (This, prior to the Dauphine Libere.)
Second, this week the UCI threatens to release a list of up to 50 drug-tainted riders against whom they've built (what they claim is) a defensible case, some of whom have biological passports that show abnormal results. If the UCI is true to its word and doesn't wimp out (no certainty) teams will be forced to deal with this list. Sponsors—especially the non-endemics—aren’t likely sit still for tainted athletes wearing kits with their names ablazoned.

Nobody knows whose names will be associated with non-conforming biological passports. But this is known: Trek with Astana, Scott with Columbia-Highroad, Cannondale with Liquigas, Giant with Rabobank, and Specialized with its three teams, will all await the list. If and when that list contains companies' sponsored riders, they have limited power to act. They can only hope that the management of these teams doesn't bring embarrassment to their bike brands. While none of these companies can predict which of its sponsored riders will cheat, Cervelo alone has the power to respond to its athletes' bad acts directly.

This lack of control over bike makers' marketing investments didn't used to be a big deal. In today's doping environment, with this much money being asked of bike sponsors, it is. To misquote Churchill: Never was so much spent by so many to so few [Pro Tour teams]. Bike companies are going to rethink spending so much money for the right to provide bikes to be ridden by athletes on teams owned and managed by many of whom came out of the drug tainted era of the 1990s.
This'll be (I predict) the high water mark for money bike makers pay for teams they don't own. It’s hard to imagine large bike companies continuing to put that much money at risk year after year; sums that represent a huge portion of their promotional and marketing costs; sweating out the wait for the possible bad news of the tainted team rider; wondering whether the millions upon millions spent annually, just for the bike sponsorship—per each of the best Pro Tour teams—will go all for naught or, worse, will conspire to hurt a company’s image.

No, for that sort of money Trek, Cannondale, Specialized, Giant, Scott, and maybe even Felt, will want their names on the jersey, first and largest (or if they're named behind a title sponsor it'll be their title sponsor, of a team they own). They'll want control of the doctors, directeurs sportif, coaches, riders, drivers, masseurs. They'll want what Cervelo has.
While Cervelo rides out its non-standard investment, Specialized appears cycling's George Steinbrenner. Maybe Specialized' gambit will pan out. Maybe one of the Schlecks will get Specialized its yellow. But isn't it nerve wracking watching star athletes (like Tom Boonen) who ride Specialized bikes get repeatedly busted for recreational drug usage? And wondering whether one of its high dollar prospects is going to be named as the carrier of a non-conforming biological passport? And knowing that you're not in control of the disposition of these cases?

Wouldn't it be better to stop buying into sponsorships of teams at their top? Rather to build, from the bottom up, a team that needs your technology? (Rather than one who tells you it needs your technology but, in fact, mostly needs your money?) In the mid-1990s Cofidis cut an athlete from its roster. That athlete couldn't find a mount. Trek made an investment. It sponsored that athlete and his team—something Trek helped build from the bottom up—and rode that investment to 7 Tour jerseys.

I'm guessing Scott, Trek, Cannondale and Giant are all closely watching the Cervelo experiment. I hope Specialized is as well. Since the non-endemic money is drying up anyway, how much better would it be for all these brands to build their own teams, not simply with their cash but with their expertise. Riis Cycling's bike company auction appears a short-term success—for Riis. In the longer term, Cervelo's reaction to the auction may represent the sustainable model.

Comment on this article

Share   

Articles related to this one
Oval Concepts' Morgan Nicol
A component maker in the heat of Continental bike racing lets fly about money, sponsorships, triathletes compared to road racers, and the (lack of) aero sophistication in the pro peloton 6.10.09
Will the credit crisis affect the bike business?
Banks and thrifts are failing, insurance companies and august houses of investment are crumbling with regularity. What about the bike biz? 10.01.08

Comments

Add your own comment

Buying Yellow 1 out of 5 stars

Reviewed by: Bryin Sills, Aug 3 2009 12:16PM

It does not matter one bit what bike a team rides. Bikes are NOT fast, riders are fast. Witness the 1956 Tour de France vs. the 2008 TDF. The 2008 race was 11% faster BUT 21% shorter. The average stage was 25 miles longer in 1956. The riders rode bikes that were 60% heavier over DIRT roads in the Alps in wool jerseys and shorts. They had nothing "aero" and still rode damn fast. 36 hole wheels were the norm, they only had 10 speeds, not 20. And the peleton was 40% smaller meaning less people to do the work so they would be slower. So I don't think what bike someone rides makes a difference. Bikes being "fast" is nonsense the bike industry spews to sell product.

Good analysis 4 out of 5 stars

Reviewed by: Karl Etzel, Jun 22 2009 8:37AM

Last year when Specialized signed with Riis I said the biggest winner, hands down, was Cervelo. I think your conclusion is spot on although I tend to agree with the earlier post that unless there is a really strong bike brand/rider link, the drug scandals don't have a large impact on the brand. Boonen can take all the coke he wants, I think the fact that he's been through a dozen iterations of one-off frames unavailable to consumers does more damage to the Specialized marketing story.

One other brand looking smart about Pro Tour (non)sponsorship is Colnago. They saw the price sky-rocketing and jumped ship.

The Taint is Faint 3 out of 5 stars

Reviewed by: Doug Roscoe, Jun 16 2009 9:24AM

I think there's a questionable assumption here: that doping scandals taint the brands that sponsored the busted rider. I'm skeptical about how much this is true. Do most cycling consumers remember what Landis was riding when he won/lost the Tour? I don't think they do. And, if they do, does it have any impact on their attitudes about that brand? I think most consumers see doping as a personal failure, not an organizational one. This is reinforced by the fact that riders jump around from team to team and sponsor to sponsor. Maybe for someone like Armstrong, who has such an identification with Trek, would the link between bike brand and rider be strong enough in people's minds.

That said, the larger point may be valid--that bike companies will want to own instead of sponsor teams. But, that would happen for purely economic reasons, not image-related ones. [Publisher's note: It was BMC. And I wonder if BMC would agree with you? Supplier of Phonak, something like 11 drug busts in 6 years (a record), and then Astana, again drug busts (Vinokourov, Mazzoleni, I don't remember how many others). Think BMC got feels it got its money's worth ;-)]

I agree 5 out of 5 stars

Reviewed by: Marcos Apene do Amaral, Jun 15 2009 6:04PM

Would love to see what you say happening!